Bayer

Wednesday, October 13, 2010 - 08:30

Since 1960, women in America have used birth control pills as a contraceptive measure. While the drugs have always been accompanied by side effects, some pills have caused worse effects than others. Public, scientific, and legal attention has been drawn to three drugs in particular, Yaz, Yasmin, and their generic equivalent, Ocella. Thousands of lawsuits are currently pending against Bayer HeathCare Pharmaceuticals.

Thursday, October 7, 2010 - 11:12

After facing legal and public scrutiny over its Yaz and Yasmin brands of birth control pills, Bayer Pharmaceuticals Inc. has announced the arrival of its new oral contraceptive, Natazia. Natazia combines an unusual dosing regimen that involves four different combinations of hormones and placebos. The drug features an estrogen hormone that has not previously been used in oral contraceptives.

Wednesday, October 6, 2010 - 11:20

A lawsuit filed by Bayer Pharmaceuticals Inc. against Watson Pharmaceuticals Inc. claiming patent infringement by Watson was dismissed by a federal judge. Watson was recently granted an approval to file an Abbreviated New Drug Application for their Yasmin generic, Zarah. Bayer originally had attempted to prevent Watson from filing the application with the Food and Drug Administration but a court denied the motion.

Tuesday, October 5, 2010 - 14:00

Despite previous concerns of harmful side effects caused by the use of Yaz and Yasmin, the U.S. Food and Drug Administration has granted Bayer Healthcare Pharmaceuticals drug approval for the new birth control pill Beyaz.

Monday, October 4, 2010 - 15:51

Lawyers in East St. Louis, IL representing plaintiffs against the pharmaceutical giant Bayer have persuaded Judge David Herndon to revise a privacy ruling that had previously been negotiated with the company.

Tuesday, April 20, 2010 - 16:02

Bayer Healthcare is once again being required by the U.S. Food and Drug Administration to update the marketing material for its popular prescription birth control medication Yaz and Yasmin. The latest update in the company’s marketing and advertising comes with new information about the drospirenone-based contraceptives and reports and accusations that Yaz and Yasmin may cause blood clots.

Tuesday, April 13, 2010 - 10:25

New research suggests that Yasmin, a popular prescription contraceptive, carries a higher risk of blood clots. An independent study was conducted by researchers at the Leiden University Medical Center in the Netherlands. The results were published in the British Medical Journal during the summer of 2009.